A comparison of reproductive risk factors for CIS lesions and invasive breast cancer
- PMID: 14696102
- DOI: 10.1002/ijc.11588
A comparison of reproductive risk factors for CIS lesions and invasive breast cancer
Abstract
A differential effect of reproductive factors on the incidence of carcinoma in situ of the breast (CIS) and invasive cancer may indicate that hormonal factors related to reproductive history not only influence the initial steps towards breast cancer but also preinvasive malignant lesions. A comparison of reproductive factors was performed using a population-based cohort of 1.5 million Danish women born between 1935 and 1978. Between 1983 and 1998, 15,590 cases of invasive breast cancer and 871 cases of CIS were identified using a database with extensive clinical information. Number of births and age at first birth were similarly associated with the risk of being diagnosed with ductal carcinoma in situ (DCIS) compared to invasive breast cancer [RR(DCIS)(per birth)/RR(invasive)(per birth) = 1.03(0.93-1.14), RR(DCIS)(per 5yr) /RR(invasive)(per 5yr) = 1.06(0.96-1.17)]. Also, the short-term risk the first 10 years after birth was similar for DCIS and invasive cancer [RR(DCIS) /RR(invasive) = 0.90 (0.74-1.09)]. Additional analyses were performed according to characteristics of the DCIS lesion (size, malignancy grade, noncomedo or comedo type). In conclusion, our observations do not support the theory that reproductive history is associated with progression from noninvasive to invasive breast cancer.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1507-14. doi: 10.1158/1055-9965.EPI-08-0967. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19423528 Free PMC article.
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.Cancer. 2006 May 15;106(10):2104-12. doi: 10.1002/cncr.21864. Cancer. 2006. PMID: 16604564
-
Is there a low-grade precursor pathway in breast cancer?Ann Surg Oncol. 2012 Apr;19(4):1115-21. doi: 10.1245/s10434-011-2053-0. Epub 2011 Sep 21. Ann Surg Oncol. 2012. PMID: 21935747
-
The natural history of ductal carcinoma in situ of the breast: a review.Breast Cancer Res Treat. 2006 May;97(2):135-44. doi: 10.1007/s10549-005-9101-z. Epub 2005 Dec 1. Breast Cancer Res Treat. 2006. PMID: 16319971 Review.
Cited by
-
Granulomatous mastitis masking ductal carcinoma in situ: A case report with literature review.Biomed Rep. 2023 Dec 8;20(2):17. doi: 10.3892/br.2023.1705. eCollection 2024 Feb. Biomed Rep. 2023. PMID: 38169821 Free PMC article.
-
Ductal carcinoma in situ of the breast: a surgical perspective.Int J Surg Oncol. 2012;2012:761364. doi: 10.1155/2012/761364. Epub 2012 Sep 4. Int J Surg Oncol. 2012. PMID: 22988495 Free PMC article.
-
Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1507-14. doi: 10.1158/1055-9965.EPI-08-0967. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19423528 Free PMC article.
-
Risk factors for young-onset invasive and in situ breast cancer.Cancer Causes Control. 2015 Dec;26(12):1771-8. doi: 10.1007/s10552-015-0670-9. Epub 2015 Sep 25. Cancer Causes Control. 2015. PMID: 26407954 Free PMC article.
-
A Randomized Trial of Calcium Plus Vitamin D Supplementation and Risk of Ductal Carcinoma In Situ of the Breast.JNCI Cancer Spectr. 2021 Aug 31;5(4):pkab072. doi: 10.1093/jncics/pkab072. eCollection 2021 Aug. JNCI Cancer Spectr. 2021. PMID: 34476342 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical